Company Profiles

driven by the PitchBook Platform

Bicycle Therapeutics

Description

Developer of a technology platform for combine features of small molecules and biopharmaceuticals. The company develops bicyclic peptide technology that enables the discovery of a new class of drug candidates with antibody-like selectivity and specificity that can be manufactured with economics similar to new chemical entities.

2009

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$43.9M

Total Amount Raised

6

Investors

Description

Developer of a technology platform for combine features of small molecules and biopharmaceuticals. The company develops bicyclic peptide technology that enables the discovery of a new class of drug candidates with antibody-like selectivity and specificity that can be manufactured with economics similar to new chemical entities.

Website:

www.bicycletherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

Meditrina Building Babraham Research Campus Cambridge CB22 3ATEngland +44 (0)12 2326 1503
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Bicycle Therapeutics's full profile, request a free trial.

Bicycle Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Bicycle Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Bicycle Therapeutics Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Astellas Venture ManagementCorporate Venture CapitalMinority000 0000000 0000
Atlas VentureVenture CapitalMinority000 0000000 0000
Novartis Venture FundsCorporate Venture CapitalMinority000 0000000 0000
SR OneCorporate Venture CapitalMinority000 0000000 0000
SV Life Sciences AdvisersVenture CapitalMinority000 0000000 0000
Astellas Venture Management Corporate Venture Capital
Atlas Venture Venture Capital
Novartis Venture Funds Corporate Venture Capital
SR One Corporate Venture Capital
SV Life Sciences Advisers Venture Capital

Bicycle Therapeutics Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Kevin Lee Ph.DChief Executive Officer & Board Member
Rosamond DeeganChief Business Officer & President
Alan Watt Ph.DInterim CSO and Head of Therapeutics
Christian Heinis Ph.DScientific Founder
Michael Skynner Ph.DVice President, Operations
Kevin Lee Ph.D Chief Executive Officer & Board Member
Rosamond Deegan Chief Business Officer & President
Alan Watt Ph.D Interim CSO and Head of Therapeutics
Christian Heinis Ph.D Scientific Founder
Michael Skynner Ph.D Vice President, Operations

Bicycle Therapeutics Board Members (11)

NameRepresentingRoleSinceContact
Info
Andrew SandhamSelfBoard Member000 0000
Anja Koenig Ph.DBicycle TherapeuticsBoard Member000 0000
Anja König Ph.DNovartis Venture FundsManaging Director000 0000
Catherine BinghamSV Life Sciences AdvisersManaging Partner000 0000
Deborah Harland Ph.DSR OnePartner000 0000
Andrew Sandham Board Member Self
Anja Koenig Ph.D Board Member Bicycle Therapeutics
Anja König Ph.D Managing Director Novartis Venture Funds
Catherine Bingham Managing Partner SV Life Sciences Advisers
Deborah Harland Ph.D Partner SR One
Request full access to PitchBook